GFAFX
Price
$77.05
Change
-$0.26 (-0.34%)
Updated
Jun 5 closing price
Net Assets
305.91B
RAFAX
Price
$36.41
Change
+$0.01 (+0.03%)
Updated
Jun 5 closing price
Net Assets
89.78B
Interact to see
Advertisement

GFAFX vs RAFAX

Header iconGFAFX vs RAFAX Comparison
Open Charts GFAFX vs RAFAXBanner chart's image
American Funds Growth Fund of Amer F1
Price$77.05
Change-$0.26 (-0.34%)
VolumeN/A
Net Assets305.91B
American Funds AMCAP R1
Price$36.41
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets89.78B
GFAFX vs RAFAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFAFX vs. RAFAX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a StrongBuy and RAFAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 306B vs. RAFAX (89.8B). GFAFX pays higher dividends than RAFAX: GFAFX (0.32) vs RAFAX (0.00). GFAFX was incepted earlier than RAFAX: GFAFX (24 years) vs RAFAX (23 years). RAFAX (1.42) is less costly to investors than GFAFX (0.67). RAFAX is a more actively managed with annual turnover of: 36.00 vs. GFAFX (25.00). GFAFX (250) and RAFAX (250) have matching initial minimum investment requirements. GFAFX annual gain was more profitable for investors over the last year : 8.56 vs. RAFAX (2.30). GFAFX return over 5 years is better than : 44.20 vs. RAFAX (18.37).
GFAFXRAFAXGFAFX / RAFAX
Total Expense Ratio0.671.4247%
Annual Report Gross Expense Ratio0.671.4247%
Fund Existence24 years23 years-
Gain YTD4.8132.825170%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets306B89.8B341%
Annual Yield % from dividends0.320.00-
Returns for 1 year8.562.30372%
Returns for 3 years37.7621.01180%
Returns for 5 years44.2018.37241%
Returns for 10 years74.1832.59228%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT19.720.16
+0.82%
Summit Therapeutics
STGW4.290.02
+0.47%
Stagwell
ZD32.820.13
+0.40%
Ziff Davis
LIDR0.75-0.01
-1.23%
AEye
TLSA1.41-0.02
-1.40%
Tiziana Life Sciences Ltd